Nuvaira Stock

Develops devices for treating lung diseases

Sign up today and learn more about Nuvaira Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Nuvaira Stock

Nuvaira, Inc. (formerly Holaira, Inc.), located in Minneapolis, Minnesota is a privately held lung denervation company developing minimally invasive products that aims to make breathing easier for patients suffering from obstructive lung diseases.

Funding History

September 2010$3.0M
May 2011$5.0M
September 2012$10.6M
February 2013$10.0M
April 2014$40.0M
February 2019$79.0M

Management

President and CEO

Dennis Wahr

Founder & CTO

Martin L. Mayse

Director of Regulatory Affairs

Mahtab Fatemi

Vice President Clinical Affairs

Jim Pavliska

CFO

Kari Kubesh

Senior Vice President Operations

Steve Mertens

Board of Directors, President and CEO

Dennis W. Wahr

Vice President International Development

Scott Grant

Press

massdevice - Sep, 29 2015

Kips Bay Medical pulls the plug

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo